5 September 2012 in Journal of Neuroscience
In the embryonic vertebrate brain, early born neurons establish highly stereotyped embryonic axonal tracts along which the neuronal interconnections form. To understand the mechanism underlying neuron axonal pathfinding within the embryonic scaffold of axon tracts, we studied zebrafish anterior dorsal telencephalic (ADt) neuron development. While previous studies suggest the ADt neuronal axons extend along a commissural tract [anterior commissure (AC)] and a descending ipsilateral tract [supraoptic tract (SOT)], it is unclear whether individual ADt neuronal axons choose specific projection paths at the intersection between the AC and the SOT. We labeled individual ADt neurons using a forebrain-specific promoter to drive expression of fluorescent proteins. We found the ADt axonal projection patterns were heterogeneous and correlated with their soma positions. Our results suggest that cell intrinsic differences along the dorsal ventral axis of the telencephalon regulate the axonal projection choices. Next, we determined that the guidance receptors roundabout2 (Robo2) and deleted in colorectal cancer (Dcc) were differentially expressed in the ADt neurons. We showed that knocking down Robo2 function by injecting antisense morpholino oligonucleotides abolished the ipsilateral SOT originating from the ADt neurons. Knocking down Dcc function did not prevent formation of the AC and the SOT. In contrast, the AC was specifically reduced when Netrin1 function was knocked down. Further mechanistic studies suggested that Robo2 responded to the repellent Slit signals and suppressed the attractive Netrin signals. These findings demonstrate how Robo2–Slit and Dcc–Netrin coordinate the axonal projection choices of the developing neurons in the vertebrate forebrain.
24 November 2022 in IEEE Access
The rapid development and wide application of the Internet of Things (IoT) and sensor technologies have produced good opportunities for the development of IoT-based smart home systems (SHSs). However, during the rapid market expansion of SHSs, security challenges associated with SHSs have become a primary concern of people because they are so closely related to people’s daily lives. These security problems may damage information assets and pose a serious threat to people’s health and life. This study investigates security issues in SHSs and provides a comprehensive overview of research to date. In this review, after analyzing the existing definition and concept of SHSs proposed by authoritative encyclopedias and academic literature, we propose a more accurate, elaborated definition of SHSs, analyze their architecture, extract six natural and contextual features, and summarize spears (cyber-attack means) vs. shields (countermeasures) in detail in the context of SHSs. Then, the security frameworks and evaluation technologies in SHSs are discussed. Different scenarios for technology integration and the practical research results in SHSs, such as blockchain, cloud computing, Internet of Vehicles, and AI are presented meticulously. After that, two special issues related to security are discussed. We believe that future research on SHS security should focus on four aspects: the unification of architecture, resource limitation, fragmentation, and code and firmware security. In addition, research on SHS security should be given priority over its commercialization process.
17 November 2021 in BMC Genomic Data
Background: Upshaw–Schulman syndrome (USS) is an autosomal recessive disease characterized by thrombotic microangiopathies caused by pathogenic variants in ADAMTS13. We aimed to (1) curate the ADAMTS13 gene pathogenic variant dataset and (2) estimate the carrier frequency and genetic prevalence of USS using Genome Aggregation Database (gnomAD) data. Methods: Studies were comprehensively retrieved. All previously reported pathogenic ADAMTS13 variants were compiled and annotated with gnomAD allele frequencies. The pooled global and population-specific carrier frequencies and genetic prevalence of USS were calculated using the Hardy-Weinberg equation. Results: We mined reported disease-causing variants that were present in the gnomAD v2.1.1, filtered by allele frequency. The pathogenicity of variants was classified according to the American College of Medical Genetics and Genomics criteria. The genetic prevalence and carrier frequency of USS were 0.43 per 1 million (95% CI: [0.36, 0.55]) and 1.31 per 1 thousand population, respectively. When the novel pathogenic/likely pathogenic variants were included, the genetic prevalence and carrier frequency were 1.1 per 1 million (95% CI: [0.89, 1.37]) and 2.1 per 1 thousand population, respectively. Conclusions: The genetic prevalence and carrier frequency of USS were within the ranges of previous estimates.
5 January 2023 in Orphanet Journal of Rare Diseases
Background: Iron-refractory iron deficiency anaemia (IRIDA) is an autosomal recessive iron deficiency anaemia caused by mutations in the TMPRSS6 gene. Iron deficiency anaemia is common, whereas IRIDA is rare. The prevalence of IRIDA is unclear. This study aimed to estimate the carrier frequency and genetic prevalence of IRIDA using Genome Aggregation Database (gnomAD) data. Methods: The pathogenicity of TMPRSS6 variants was interpreted according to the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) standards and guidelines. The minor allele frequency (MAF) of TMPRSS6 gene disease-causing variants in 141,456 unique individuals was examined to estimate the global prevalence of IRIDA in seven ethnicities: African/African American (afr), American Admixed/Latino (amr), Ashkenazi Jewish (asj), East Asian (eas), Finnish (fin), Non-Finnish European (nfe) and South Asian (sas). The global and population-specific carrier frequencies and genetic prevalence of IRIDA were calculated using the Hardy–Weinberg equation. Results: In total, 86 pathogenic/likely pathogenic variants (PV/LPV) were identified according to ACMG/AMP guideline. The global carrier frequency and genetic prevalence of IRIDA were 2.02 per thousand and 1.02 per million, respectively. Conclusions: The prevalence of IRIDA is greater than previous estimates.